4094 results
Radiodiagnostics strongly depends on high image or data quality, well-performed image analyses and information on how pathology appears on the image or data acquired. The objectives of the study are: - In order to improve radiodiagnostic imaging, it…
Studies have shown that generation of lung cells from human pluripotent stem cells is possible. The present study aims to develop cell cultures, such as 3D mini lung structures from skin cells from subjects with ILD and/or their family members. The…
Objective:The life-time risk for POP surgery is 20%, and 30% of these women will need surgery because of a recurrence. VaginalPOP surgery (VH, SSH and MM) is the first choice surgical treatment. The numbers of uterus sparing operations (SSH andMM)…
The primary objective is to prove non-inferiority of thermal ablation compared to hepatic resection in patients with at least one resectable and ablatable CRLM (<=3cm) and no extrahepatic disease.
This study has been transitioned to CTIS with ID 2023-508925-29-00 check the CTIS register for the current data. Primary: To characterize safety and tolerability of TNO155 and identify a recommended dose and regimen for future studies in adult…
The primary end-point is ipsilateral invasive breast tumor-free rate at 10 years. Secondary end-points are among others: overall survival, breast cancer-specific survival, mastectomy rate and patient reported outcomes.To determine whether low- risk…
The main goal of this study is to study the accuracy (sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and false negative rate (FNR)) of dedicated axillary hybrid PET/MRI for the detection of negative…
zie protocol
The iMODERN trial will compare iFR-guided revascularization of noninfarct lesions during acute intervention with a stress perfusion CMR-guided strategy during the outpatient follow-up, to determine the optimal therapeutic approach for STEMI patients…
The primary objective of this study is to determine the immune-activating capacity of treatment with pembrolizumab and carboplatin/paclitaxel in the neo-adjuvant setting of primary stage IV ovarian cancer as measured by the alteration in magnitude…
This study has been transitioned to CTIS with ID 2024-511322-31-00 check the CTIS register for the current data. To evaluate whether in newborns with asphyxia and early clinical signs of hypoxic ischemic encephalopathy, early postnatal allopurinol…
Primary Objectives* To evaluate the efficacy of SCY-078 as determined by a Data Monitoring Committee(DMC) by assessing global success (composite assessment of clinical and mycologicalsuccess) at EoT* To evaluate the safety of SCY-078
To confirm the efficacy and safety of a single intra-arterial administration of REX-001 to treat ischemic ulcers in subjects with CLTI Rutherford Category 5 and DM.
To evaluate the safety of an endoscopic follow-up strategy in patients with HR T1a and T1b N0M0 esophageal adenocarcinoma (EAC).
Primary Objective There are two co-primary objectives; one regarding each tibial component configuration, fixed bearing (FB) and rotating platform (RP): 1) Evaluate change from preoperative baseline to the 2 yr timepoint in patient reported…
This study has been transitioned to CTIS with ID 2022-501784-40-00 check the CTIS register for the current data. The study aims to demonstrate that treatment with nivolumab combined with ipilimumab will improve efficacy in cisplatin-ineligible…
Objective 1)To determine the cost-effectiveness of screening for and preventive treatment of UIAs in persons with FDRs with UIAs. We will therefore assess the prevalence of UIA in persons with >=1 FDR with an UIA, the costs of the screening,…
The primary objective is to evaluate whether the impact of a strategy aimed at switching INR-guided VKA management to a NOAC-based treatment strategy is superior in terms of the occurrence of major or clinically relevant non-major bleeding…
The objective of this study is to investigate the safety and effectiveness of different combinations of cancer immunotherapies compared to either Nivolumab or Ipilimumab, as determined by comparing the Overall Response Rate, at 24 weeks in patients…
Objective: To collect a broad array of clinical, behavioural, physical and biochemical parameters, to ensure that many clinical research questions or problems related to successful aging with T1D can be answered. Nevertheless, we have a priori…